India
India nyatakeun ibukota kanker dunya - laporan Apollo
India declared cancer capital of the world India was designated as the "cancer capital of the world" in the 4th edition of Apollo Hospitals' Health of the Nation Report, which was published on World Health Day 2024. According ..
Cina, India
Kumaha Pencitraan Diagnostik Nyalametkeun Kahirupan di Multiple Myeloma Battles?
Curious about how a medical technique is saving the lives of multiple myeloma patients? Read our blog to learn more about this life-saving technique! Let's turn the page on cancer together. Your story of hope starts here. Hell..
India
Rumah sakit kanker pangsaéna di India taun 2023
Here's the list of the best cancer hospitals in India:. The list is very carefully prepared, keeping in mind the use of the latest technology to treat cancer, ongoing research projects in the hospital, ongoing clinical trials in ..
Béta Thalassemia, BMT, Covid-19, India, Talasemia
Béta Thalassemia sareng pertimbanganana sareng COVID-19
July 2021: Beta-thalassemia is an inherited condition caused by mutations in a gene involved in the production of a component of haemoglobin, the protein that transports oxygen throughout the body. These mutations either prohibit ..
bedah Bariatric, Cirebon, India, AS
Operasi bariatric tiasa ngirangan résiko melanoma
Salaku tambahan pikeun leungitna beurat gancang sareng awét sareng kauntungan kaséhatan anu sanés, bedah bariatric ayeuna dikaitkeun sareng 61% résiko ngirangan melanoma ganas, anu mangrupikeun kanker kulit anu paling parah anu pakait pisan sareng s ..
Mobil - Terapi sél T, Cina, India, anggapanana, AS
Strategi anyar pikeun imunoterapi sababaraha myeloma
Dina dasawarsa terakhir, pangobatan kanker dumasar-antibodi monoclonal parantos diadegkeun salaku salah sahiji stratégi pangobatan anu paling suksés pikeun tumor padet sareng kanker getih. Sakumaha namina namina, antibodi monoklonal (mAbs) mangrupikeun antibo ..
Cina, harga, gastric, Gastroenterology, India, Israél, Singapura, Beuteung, anggapanana, AS
Terus-terusan nginum obat ieu tiasa ngalipet résiko kanker lambung
Panilitian anu diterbitkeun dina "Intestine" nunjukkeun yén panggunaan jangka panjang sambetan pompa proton bakal ngadua résiko kanker lambung. Inhibitor pompa proton mangrupikeun kelas ubar anu dianggo pikeun ngarawat réfluks asam lambung. , Pamakéan anu teras-terasan pikeun ..
Cina, India, Israél, Ramucirumab, Singapura, anggapanana, AS
Ramucirumab dina ngubaran kanker lambung
Numutkeun kana statistik, penderita kanker lambung anu diubaran di Amérika Serikat, Éropa, sareng Jepang sering disarankeun nganggo ramucirumab dikombinasikeun sareng ubar sanésna pikeun ngubaran kanker lambung. US Food and Drug Administra ..
Cina, Terapi kombinasi, India, ati, Sambetan PD-1, Roche, AS
Terapi kombinasi kanker ati inhibitor Roche PD-1 diaku ku FDA salaku terapi terobosan
Grup Swiss Roche ngumumkeun kamari yén TECENTRIQ® (atezolizumab) dina kombinasi sareng Avastin® (bevacizumab) parantos disahkeun ku Administrasi Pangan sareng Narkoba AS (FDA) pikeun terapi terobosan kanggo awal (garis kahiji) ..
Cabozantinib, Cina, India, ati, AS
Cabozantinib manjangan salamet bébas kamajuan pikeun kanker ati maju
Numutkeun kana panilitian anu diterbitkeun dina New England Journal of Medicine anu diterbitkeun tanggal 5 Juli, kasalametan Cabozantinib sacara bébas sareng kamajuan bébas dina penderita karsinoma hepatosélular anu maju sacara signifikan langkung saé tibatan p ..